Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 515

1.

Cost analysis and efficacy of recruitment strategies used in a large pragmatic community-based clinical trial targeting low-income seniors: a comparative descriptive analysis.

Kakumanu S, Manns BJ, Tran S, Saunders-Smith T, Hemmelgarn BR, Tonelli M, Tsuyuki R, Ivers N, Southern D, Bakal J, Campbell DJT.

Trials. 2019 Oct 7;20(1):577. doi: 10.1186/s13063-019-3652-5.

2.

Barriers and facilitators for implementation of electronic consultations (eConsult) to enhance access to specialist care: a scoping review.

Osman MA, Schick-Makaroff K, Thompson S, Bialy L, Featherstone R, Kurzawa J, Zaidi D, Okpechi I, Habib S, Shojai S, Jindal K, Braam B, Keely E, Liddy C, Manns B, Tonelli M, Hemmelgarn B, Klarenbach S, Bello AK.

BMJ Glob Health. 2019 Sep 13;4(5):e001629. doi: 10.1136/bmjgh-2019-001629. eCollection 2019.

3.

A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH).

Tam-Tham H, Clement F, Hemmelgarn BR, Manns BJ, Klarenbach SW, Tonelli M, Tsuyuki RT, Al Hamarneh YN, Penko J, Weaver CGW, Au F, Weaver RG, Jones CA, McBrien KA.

Value Health. 2019 Oct;22(10):1128-1136. doi: 10.1016/j.jval.2019.05.012. Epub 2019 Aug 17.

PMID:
31563255
4.

Patient-reported outcomes in Alberta: rationale, scope, and design of a database initiative.

Cuthbert CA, Watson L, Xu Y, Boyne DJ, Hemmelgarn BR, Cheung WY.

Curr Oncol. 2019 Aug;26(4):e503-e509. doi: 10.3747/co.26.4919. Epub 2019 Aug 1.

5.

Influence of Mortality on Estimating the Risk of Kidney Failure in People with Stage 4 Chronic Kidney Disease.

Ravani P, Fiocco M, Liu P, Quinn RR, Hemmelgarn B, James M, Lam N, Manns B, Oliver MJ, Strippoli GFM, Tonelli M.

J Am Soc Nephrol. 2019 Sep 20. pii: ASN.2019060640. doi: 10.1681/ASN.2019060640. [Epub ahead of print]

PMID:
31540963
6.

Data variability across Canadian administrative health databases: Differences in content, coding, and completeness.

Doyle CM, Lix LM, Hemmelgarn BR, Paterson JM, Renoux C.

Pharmacoepidemiol Drug Saf. 2019 Sep 10. doi: 10.1002/pds.4889. [Epub ahead of print]

PMID:
31507029
7.

Dataset of clinical laboratory tests according to ordering variance among family physicians in Calgary, Alberta, Canada.

Nguyen LT, Guo M, Hemmelgarn B, Quan H, Clement F, Sajobi T, Thomas R, Turin TC, Naugler C.

Data Brief. 2019 Aug 12;25:104387. doi: 10.1016/j.dib.2019.104387. eCollection 2019 Aug.

8.

Correction to: Methods for identifying 30 chronic conditions: application to administrative data.

Tonelli M, Wiebe N, Fortin M, Guthrie B, Hemmelgarn BR, James MT, Klarenbach SW, Lewanczuk R, Manns BJ, Ronksley P, Sargious P, Straus S, Quan H; Alberta Kidney Disease Network.

BMC Med Inform Decis Mak. 2019 Sep 4;19(1):177. doi: 10.1186/s12911-019-0900-2.

9.

Self-management interventions for cancer survivors: A systematic review and evaluation of intervention content and theories.

Cuthbert CA, Farragher JF, Hemmelgarn BR, Ding Q, McKinnon GP, Cheung WY.

Psychooncology. 2019 Sep 2. doi: 10.1002/pon.5215. [Epub ahead of print] Review.

PMID:
31475766
10.

Challenges and potential solutions to the evaluation, monitoring, and regulation of surgical innovations.

Roberts DJ, Zygun DA, Ball CG, Kirkpatrick AW, Faris PD, James MT, Mrklas KJ, Hemmelgarn BD, Manns B, Stelfox HT.

BMC Surg. 2019 Aug 27;19(1):119. doi: 10.1186/s12893-019-0586-5.

11.

Association of Mental Health Disorders With Health Care Utilization and Costs Among Adults With Chronic Disease.

Sporinova B, Manns B, Tonelli M, Hemmelgarn B, MacMaster F, Mitchell N, Au F, Ma Z, Weaver R, Quinn A.

JAMA Netw Open. 2019 Aug 2;2(8):e199910. doi: 10.1001/jamanetworkopen.2019.9910.

12.

Content and Quality of Websites for Patients With Chronic Kidney Disease: An Environmental Scan.

Smekal M, Gil S, Donald M, Beanlands H, Straus S, Herrington G, Sparkes D, Harwood L, Tong A, Grill A, Tu K, Waldvogel B, Large C, Large C, Novak M, James M, Elliott M, Delgado M, Brimble S, Samuel S, Hemmelgarn BR.

Can J Kidney Health Dis. 2019 Jul 30;6:2054358119863091. doi: 10.1177/2054358119863091. eCollection 2019.

13.

Protocol for a pilot randomised controlled trial of an educational programme for adults on chronic haemodialysis with fatigue (Fatigue-HD).

Farragher JF, Thomas C, Ravani P, Manns B, Elliott MJ, Hemmelgarn BR.

BMJ Open. 2019 Jul 30;9(7):e030333. doi: 10.1136/bmjopen-2019-030333.

14.

Characteristics of Adults With Type 2 Diabetes Mellitus by Category of Chronic Kidney Disease and Presence of Cardiovascular Disease in Alberta Canada: A Cross-Sectional Study.

Tonelli M, Wiebe N, Richard JF, Klarenbach SW, Hemmelgarn BR.

Can J Kidney Health Dis. 2019 Jun 13;6:2054358119854113. doi: 10.1177/2054358119854113. eCollection 2019.

15.

Evaluating practice variance among family physicians to identify targets for laboratory utilization management.

Nguyen LT, Guo M, Hemmelgarn B, Quan H, Clement F, Sajobi T, Thomas R, Turin TC, Naugler C.

Clin Chim Acta. 2019 Oct;497:1-5. doi: 10.1016/j.cca.2019.06.017. Epub 2019 Jun 19.

PMID:
31228416
16.

Understanding Adults With Chronic Kidney Disease and Their Caregivers' Self-Management Experiences: A Qualitative Study Using the Theoretical Domains Framework.

Baay S, Hemmelgarn B, Tam-Tham H, Finlay J, Elliott MJ, Straus S, Beanlands H, Herrington G, Donald M.

Can J Kidney Health Dis. 2019 May 22;6:2054358119848126. doi: 10.1177/2054358119848126. eCollection 2019.

17.

Patient-Reported Outcome Measures in CKD Care: The Importance of Demonstrating Need and Value.

Elliott MJ, Hemmelgarn BR.

Am J Kidney Dis. 2019 Aug;74(2):148-150. doi: 10.1053/j.ajkd.2019.04.014. Epub 2019 Jun 11. No abstract available.

PMID:
31200974
18.

Joint associations of obesity and estimated GFR with clinical outcomes: a population-based cohort study.

Tonelli M, Wiebe N, Kovesdy CP, James MT, Klarenbach SW, Manns BJ, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Jun 6;20(1):204. doi: 10.1186/s12882-019-1351-9.

19.

The Cost of Care for People With Chronic Kidney Disease.

Manns B, Hemmelgarn B, Tonelli M, Au F, So H, Weaver R, Quinn AE, Klarenbach S; for Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease.

Can J Kidney Health Dis. 2019 Apr 4;6:2054358119835521. doi: 10.1177/2054358119835521. eCollection 2019.

20.

Identifying Needs for Self-management Interventions for Adults With CKD and Their Caregivers: A Qualitative Study.

Donald M, Beanlands H, Straus S, Ronksley P, Tam-Tham H, Finlay J, MacKay J, Elliott M, Herrington G, Harwood L, Large CA, Large CL, Waldvogel B, Sparkes D, Delgado M, Tong A, Grill A, Novak M, James MT, Brimble KS, Samuel S, Hemmelgarn BR.

Am J Kidney Dis. 2019 Oct;74(4):474-482. doi: 10.1053/j.ajkd.2019.02.006. Epub 2019 Apr 2.

PMID:
30952486
21.

Incidence and Prognosis of Acute Kidney Diseases and Disorders Using an Integrated Approach to Laboratory Measurements in a Universal Health Care System.

James MT, Levey AS, Tonelli M, Tan Z, Barry R, Pannu N, Ravani P, Klarenbach SW, Manns BJ, Hemmelgarn BR.

JAMA Netw Open. 2019 Apr 5;2(4):e191795. doi: 10.1001/jamanetworkopen.2019.1795.

22.

Patient and provider experience and perspectives of a risk-based approach to multidisciplinary chronic kidney disease care: a mixed methods study.

Smekal MD, Tam-Tham H, Finlay J, Donald M, Thomas C, Weaver RG, Quinn RR, Tam K, Manns BJ, Tonelli M, Bello A, Tangri N, Hemmelgarn BR.

BMC Nephrol. 2019 Mar 29;20(1):110. doi: 10.1186/s12882-019-1269-2.

23.

Statin use and the risk of acute kidney injury in older adults.

Tonelli M, Lloyd AM, Bello AK, James MT, Klarenbach SW, McAlister FA, Manns BJ, Tsuyuki RT, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Mar 25;20(1):103. doi: 10.1186/s12882-019-1280-7.

24.

Increasing access to integrated ESKD care as part of universal health coverage.

Harris DCH, Davies SJ, Finkelstein FO, Jha V, Donner JA, Abraham G, Bello AK, Caskey FJ, Garcia GG, Harden P, Hemmelgarn B, Johnson DW, Levin NW, Luyckx VA, Martin DE, McCulloch MI, Moosa MR, O'Connell PJ, Okpechi IG, Pecoits Filho R, Shah KD, Sola L, Swanepoel C, Tonelli M, Twahir A, van Biesen W, Varghese C, Yang CW, Zuniga C; Working Groups of the International Society of Nephrology’s 2nd Global Kidney Health Summit.

Kidney Int. 2019 Apr;95(4S):S1-S33. doi: 10.1016/j.kint.2018.12.005. Review.

25.

Red cell distribution width associations with clinical outcomes: A population-based cohort study.

Tonelli M, Wiebe N, James MT, Naugler C, Manns BJ, Klarenbach SW, Hemmelgarn BR.

PLoS One. 2019 Mar 13;14(3):e0212374. doi: 10.1371/journal.pone.0212374. eCollection 2019.

26.

Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study.

Liu P, Quinn RR, Karim ME, Bello A, Tam-Tham H, Weaver R, Ronksley PE, Quan H, Strippoli GFM, Manns B, Hemmelgarn BR, Tonelli M, Ravani P.

CMAJ. 2019 Mar 11;191(10):E274-E282. doi: 10.1503/cmaj.181372.

27.

Outcomes Following Macrolide Use in Kidney Transplant Recipients.

Jeong R, Quinn RR, Lentine KL, Lloyd A, Ravani P, Hemmelgarn B, Braam B, Garg AX, Wen K, Wong-Chan A, Gourishankar S, Lam NN.

Can J Kidney Health Dis. 2019 Feb 21;6:2054358119830706. doi: 10.1177/2054358119830706. eCollection 2019.

28.

The association between payment model and specialist physicians' selection of patients with diabetes: a descriptive study.

Quinn AE, Edwards A, Senior P, McBrien KA, Hemmelgarn BR, Tonelli M, Au F, Ma Z, Weaver RG, Manns BJ.

CMAJ Open. 2019 Feb 18;7(1):E109-E116. doi: 10.9778/cmajo.20180171. Print 2019 Jan-Mar.

29.

Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System.

Tonelli M, Wiebe N, Manns BJ, Klarenbach SW, James MT, Ravani P, Pannu N, Himmelfarb J, Hemmelgarn BR.

JAMA Netw Open. 2018 Nov 2;1(7):e184852. doi: 10.1001/jamanetworkopen.2018.4852. Erratum in: JAMA Netw Open. 2019 Mar 1;2(3):e190147.

30.

Change in Proteinuria or Albuminuria as a Surrogate for Cardiovascular and Other Major Clinical Outcomes: A Systematic Review and Meta-analysis.

Harrison TG, Tam-Tham H, Hemmelgarn BR, Elliott M, James MT, Ronksley PE, Jun M.

Can J Cardiol. 2019 Jan;35(1):77-91. doi: 10.1016/j.cjca.2018.10.014. Epub 2018 Oct 29. Review.

PMID:
30595186
31.

Effectiveness and components of self-management interventions in adult cancer survivors: a protocol for a systematic review and planned meta-analysis.

Cuthbert CA, Samawi HH, Hemmelgarn BR, Cheung WY.

Syst Rev. 2018 Dec 20;7(1):238. doi: 10.1186/s13643-018-0902-7.

32.

Exploring structural barriers to diabetes self-management in Alberta First Nations communities.

Kulhawy-Wibe S, King-Shier KM, Barnabe C, Manns BJ, Hemmelgarn BR, Campbell DJT.

Diabetol Metab Syndr. 2018 Dec 3;10:87. doi: 10.1186/s13098-018-0385-7. eCollection 2018.

33.

Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.

Lam NN, Klarenbach S, Quinn RR, Hemmelgarn B, Tonelli M, Ye F, Ravani P, Bello AK, Brennan DC, Lentine KL.

Transplant Direct. 2018 Sep 6;4(10):e389. doi: 10.1097/TXD.0000000000000828. eCollection 2018 Oct.

34.

Identification and Prioritization of Quality Indicators for Conservative Kidney Management.

Harrison TG, Tam-Tham H, Hemmelgarn BR, James MT, Sinnarajah A, Thomas CM.

Am J Kidney Dis. 2019 Feb;73(2):174-183. doi: 10.1053/j.ajkd.2018.08.014. Epub 2018 Oct 25.

PMID:
30482578
35.

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.

Brar S, Ye F, James MT, Hemmelgarn B, Klarenbach S, Pannu N; Interdisciplinary Chronic Disease Collaboration.

JAMA Intern Med. 2018 Dec 1;178(12):1681-1690. doi: 10.1001/jamainternmed.2018.4749.

PMID:
30422153
36.

Perceived Significance of Engagement in Research Prioritization Among Chronic Kidney Disease Patients, Caregivers, and Health Care Professionals: A Qualitative Study.

Elliott MJ, Goodarzi Z, Sale JEM, Wilhelm LA, Laupacis A, Hemmelgarn BR, Straus SE.

Can J Kidney Health Dis. 2018 Oct 19;5:2054358118807480. doi: 10.1177/2054358118807480. eCollection 2018.

37.

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.

Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, Tugwell P, Pecoits-Filho R, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Levin A, Thompson A, Perkovic V, Ju A, Gutman T, Bernier-Jean A, Viecelli AK, O'Lone E, Shen J, Josephson MA, Cho Y, Johnson DW, Sautenet B, Tonelli M, Craig JC; SONG Implementation Workshop Investigators.

Kidney Int. 2018 Dec;94(6):1053-1068. doi: 10.1016/j.kint.2018.08.018. Epub 2018 Oct 22.

PMID:
30360959
38.

Pharmacist prescribing and care improves cardiovascular risk, but what do patients think? A substudy of the RxEACH study.

Al Harmarneh YN, Lamb S, Donald M, Hemmelgarn B, King Shier K, Jones CA, Mitchell C, Tsuyuki RT.

Can Pharm J (Ott). 2018 May 30;151(4):223-227. doi: 10.1177/1715163518779092. eCollection 2018 Jul-Aug. No abstract available.

39.

Sustaining knowledge translation interventions for chronic disease management in older adults: protocol for a systematic review and network meta-analysis.

Tricco AC, Moore JE, Beben N, Brownson RC, Chambers DA, Dolovich LR, Edwards A, Fairclough L, Glasziou PP, Graham ID, Hemmelgarn BR, Holmes B, Isaranuwatchai W, Lachance CC, Legare F, McGowan J, Majumdar SR, Presseau J, Squires JE, Stelfox HT, Strifler L, Thompson K, Van der Weijden T, Veroniki AA, Straus SE.

Syst Rev. 2018 Sep 15;7(1):140. doi: 10.1186/s13643-018-0808-4.

40.

The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study.

Cuthbert CA, Hemmelgarn BR, Xu Y, Cheung WY.

J Cancer Surviv. 2018 Dec;12(6):733-743. doi: 10.1007/s11764-018-0710-z. Epub 2018 Sep 6.

PMID:
30191524
41.

Long-term views on chronic kidney disease research priorities among stakeholders engaged in a priority-setting partnership: A qualitative study.

Elliott MJ, Sale JEM, Goodarzi Z, Wilhelm L, Laupacis A, Hemmelgarn BR, Straus SE.

Health Expect. 2018 Dec;21(6):1142-1149. doi: 10.1111/hex.12818. Epub 2018 Aug 15.

42.

Follow-up Care of Living Kidney Donors in Alberta, Canada.

Lam NN, Lentine KL, Hemmelgarn B, Klarenbach S, Quinn RR, Lloyd A, Gourishankar S, Garg AX.

Can J Kidney Health Dis. 2018 Jul 26;5:2054358118789366. doi: 10.1177/2054358118789366. eCollection 2018.

43.

Enhancing the uptake of systematic reviews of effects: what is the best format for health care managers and policy-makers? A mixed-methods study.

Marquez C, Johnson AM, Jassemi S, Park J, Moore JE, Blaine C, Bourdon G, Chignell M, Ellen ME, Fortin J, Graham ID, Hayes A, Hamid J, Hemmelgarn B, Hillmer M, Holmes B, Holroyd-Leduc J, Hubert L, Hutton B, Kastner M, Lavis JN, Michell K, Moher D, Ouimet M, Perrier L, Proctor A, Noseworthy T, Schuckel V, Stayberg S, Tonelli M, Tricco AC, Straus SE.

Implement Sci. 2018 Jun 22;13(1):84. doi: 10.1186/s13012-018-0779-9. Review.

44.

Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.

Veroniki AA, Antony J, Straus SE, Ashoor HM, Finkelstein Y, Khan PA, Ghassemi M, Blondal E, Ivory JD, Hutton B, Gough K, Hemmelgarn BR, Lillie E, Vafaei A, Tricco AC.

PLoS One. 2018 Jun 18;13(6):e0198447. doi: 10.1371/journal.pone.0198447. eCollection 2018.

45.

Effectiveness, Complications, and Costs of Rheumatoid Arthritis Treatment with Biologics in Alberta: Experience of Indigenous and Non-indigenous Patients.

Barnabe C, Zheng Y, Ohinmaa A, Crane L, White T, Hemmelgarn B, Kaplan GG, Martin L, Maksymowych WP.

J Rheumatol. 2018 Oct;45(10):1344-1352. doi: 10.3899/jrheum.170779. Epub 2018 Jun 1.

PMID:
29858236
46.

Risk Factors for Prognosis in Patients With Severely Decreased GFR.

Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt KU, Hemmelgarn B, Wheeler DC.

Kidney Int Rep. 2018 Jan 11;3(3):625-637. doi: 10.1016/j.ekir.2018.01.002. eCollection 2018 May. Erratum in: Kidney Int Rep. 2018 Aug 30;3(6):1506.

47.

Overview of Self-Management Resources Used by Canadian Chronic Kidney Disease Clinics: A National Survey.

Donald M, Gil S, Kahlon B, Beanlands H, Straus S, Herrington G, Manns B, Hemmelgarn BR.

Can J Kidney Health Dis. 2018 May 22;5:2054358118775098. doi: 10.1177/2054358118775098. eCollection 2018.

48.

Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.

Tam-Tham H, Quinn RR, Weaver RG, Zhang J, Ravani P, Liu P, Thomas C, King-Shier K, Fruetel K, James MT, Manns BJ, Tonelli M, Murtagh FEM, Hemmelgarn BR.

Kidney Int. 2018 Sep;94(3):582-588. doi: 10.1016/j.kint.2018.03.007. Epub 2018 May 24.

PMID:
29803405
49.

Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study.

Tong A, Crowe S, Gill JS, Harris T, Hemmelgarn BR, Manns B, Pecoits-Filho R, Tugwell P, van Biesen W, Wang AYM, Wheeler DC, Winkelmayer WC, Gutman T, Ju A, O'Lone E, Sautenet B, Viecelli A, Craig JC.

BMJ Open. 2018 Apr 20;8(4):e021198. doi: 10.1136/bmjopen-2017-021198.

50.

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJL, Pollock CA, Stevens PE, Tamura MK, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR; Conference Participants.

Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006. Epub 2018 Apr 12.

Supplemental Content

Loading ...
Support Center